Structure Therapeutics Inc. - 10-Q Filing
Structure Therapeutics filed its quarterly report for the period ended March 31, 2026, providing financial updates and details on equity compensation plans. The filing includes data related to retained earnings, additional paid-in capital, accumulated other comprehensive income, common stock balances as of key dates (March 31, December 31), and performance share units tied to employee compensation for the first quarter of 2026.
Tickers: $GPCR